BKD vs ENSG: Which Is the Better Buy in 2026?
Last updated August 2026
Short answer
BKD and ENSG are similarly sized, but ENSG trades noticeably cheaper on forward earnings (20.83x vs 71.22x): the market is paying up for BKD's profile and pricing ENSG more conservatively, or for faster growth. Which you prefer comes down to the drivers you believe, and whether adding either over-concentrates what you already own.
BKD vs ENSG: the tie-breaker metrics
Same yardstick, side by side (as of August 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.
| Metric | BKD | ENSG | What it tells you |
|---|---|---|---|
| Forward P/E | 71.22 | 20.83 | Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up. |
| Beta | 0.58 | 0.69 | Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through. |
| Price vs 52-week range | 75% of range | 48% of range | Where today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why. |
Reading it: ENSG is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.
Before you buy: how BKD and ENSG affect your concentration
The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. BKD and ENSG share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.
This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined BKD and ENSG exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.
What does Brookdale Senior Living (BKD) do?
Brookdale Senior Living (NYSE: BKD) is the largest operator of senior living communities in the United States, running hundreds of independent living, assisted living, and memory care communities across the country. It generates revenue mainly from resident fees, so its results track occupancy (how full its communities are), pricing power (rate increases per unit), and its ability to manage labor and real estate costs. After the pandemic gutted occupancy across the sector, Brookdale has been rebuilding move-in volume and pushing through rate increases, and it owns a large portion of its real estate, which adds asset value but also mortgage debt.
What does The Ensign Group (ENSG) do?
The Ensign Group runs a network of independently operated skilled nursing facilities, senior living communities, and rehabilitation services across the United States, plus a growing real estate arm (Standard Bearer). As of mid-2026 its subsidiaries operated roughly 398 healthcare operations, including about 48 senior living communities, across 17 states, with a real estate portfolio of roughly 183 properties. The business model is to acquire underperforming but strategically located facilities and turn them into profitable local operations, generating revenue mostly from Medicare, Medicaid, and private-insurance reimbursement for short-term rehab and long-term care.
BKD vs ENSG: how do they differ?
Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.
- BKD drivers: Occupancy and pricing recovery; Aging demographics tailwind.
- ENSG drivers: Serial-acquisition growth engine; Occupancy and skilled-mix gains.
Which fits which kind of investor
A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: The dominant risk is leverage: Brookdale carries substantial debt and mortgage maturities, so higher-for-longer interest rates or tight credit markets could raise refinancing costs or pressure the balance sheet. For ENSG, ensign derives the majority of its revenue from Medicare and Medicaid, so any cut, freeze, or unfavorable change to government reimbursement rates would pressure margins directly.
BKD or ENSG: which should you pick?
BKD vs ENSG: the full fundamentals
BKD. Brookdale trades as a leveraged operating turnaround rather than a profit-stable name, with trailing revenue around $3.05 billion and a market cap in the low single-digit billions as of JULY 2026. Adjusted EBITDA has been growing on better occupancy and pricing, but the company still posted a full year 2025 GAAP net loss of roughly $263 million and a slightly negative net margin. Debt levels mean enterprise value is considerably larger than market cap, so valuation depends heavily on the trajectory of occupancy and refinancing.
ENSG. Ensign trades at a premium to typical healthcare-facility peers, reflecting its consistent double-digit growth and strong balance sheet (roughly $540 million cash against about $143 million of debt in early 2026). Q1 2026 revenue grew about 18% year over year to roughly $1.39 billion with adjusted EPS up more than 20%, and management raised full-year guidance. The premium multiple assumes the acquisition-led growth continues.
Headline figures (approximate, JULY 2026): BKD shows revenue (ttm) ~$3.05B, q1 2026 revenue ~$765M, fy2025 net loss ~$263M, fy2025 adjusted ebitda ~$458M; ENSG shows revenue (ttm) ~$5.3B, 2026 revenue guidance ~$5.81B to $5.86B, 2026 eps guidance (diluted) ~$7.48 to $7.62, market cap ~$9.9B.
The bottom line: BKD vs ENSG
BKD and ENSG are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined BKD and ENSG exposure against your real portfolio. It is not an investment adviser.
Wondering how BKD or ENSG fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.
Investing in Brookdale Senior Living with AI
Connect the broker you already use and ask Walnut's AI how BKD fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.
FAQ
What is the difference between BKD and ENSG?
+
Brookdale Senior Living (NYSE: BKD) is the largest operator of senior living communities in the United States, running hundreds of independent living, assisted living, and memory care communities across the country. The Ensign Group runs a network of independently operated skilled nursing facilities, senior living communities, and rehabilitation services across the United States, plus a growing real estate arm (Standard Bearer). They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.
Is BKD or ENSG the better stock?
+
Neither is universally better; they suit different views and risk levels. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.
Which is cheaper, BKD or ENSG?
+
On forward P/E (as of August 2026), BKD trades at 71.22x and ENSG at 20.83x, so ENSG is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.
Should you own both BKD and ENSG?
+
Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.
What are the risks of BKD vs ENSG?
+
BKD: The dominant risk is leverage: Brookdale carries substantial debt and mortgage maturities, so higher-for-longer interest rates or tight credit markets could raise refinancing costs or pressure the balance sheet. The company still reports GAAP net losses and thin or negative net margins, so profitability is not yet proven through a full cycle. Labor costs and staffing availability are structural pressures in senior care, and any renewed drop in occupancy (from a demand shock, a health scare, or new supply) would hit a high-fixed-cost model hard. Regulatory, liability, and reimbursement dynamics in senior care add further uncertainty, and the stock has historically been volatile. ENSG: Ensign derives the majority of its revenue from Medicare and Medicaid, so any cut, freeze, or unfavorable change to government reimbursement rates would pressure margins directly. The skilled nursing industry is labor-intensive and exposed to persistent workforce shortages and wage inflation, and proposed federal minimum-staffing mandates could raise costs if reinstated. Growth depends on continuously finding and integrating acquisitions at attractive prices, so a slower pipeline or integration missteps would slow the compounding. The stock also trades at a premium valuation, which leaves less cushion if growth decelerates. Finally, the sector carries regulatory, litigation, and quality-of-care compliance risk that can produce fines or reputational damage.
Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell BKD or ENSG; figures are approximate and dated (as of August 2026). Verify current data before investing.